Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient’s kneecap during knee replacement surgery.
The company raised an initial £1.4 million in 2021. Funds will support production, FDA marketing clearance and growing Eventum’s sales and technical team from five to twelve.
Thus far, Eventum Orthopaedics’ device has been used with robotic surgery in 20 procedures in New Zealand.
Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient's kneecap during knee replacement surgery.
The company raised an...
Eventum Orthopaedics raised £2.5 million (~USD $3.0 million) in a Series A round for its Quadsense knee replacement surgery device that lets orthopedic surgeons record the strength of a person’s quadriceps muscle. The measurement can assist surgeons when positioning a patient’s kneecap during knee replacement surgery.
The company raised an initial £1.4 million in 2021. Funds will support production, FDA marketing clearance and growing Eventum’s sales and technical team from five to twelve.
Thus far, Eventum Orthopaedics’ device has been used with robotic surgery in 20 procedures in New Zealand.
Copy to clipboard 
